A breakthrough in HIV prevention
Early data from the CTN 268 – ANRS IPERGAY trial validates ‘on demand’ pre-exposure prophylaxis...
Learn MoreEarly data from the CTN 268 – ANRS IPERGAY trial validates ‘on demand’ pre-exposure prophylaxis...
Learn MoreCTN researchers part of global strategy to find a cure The CTN’s Vaccines and Immunotherapies...
Learn More